Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000909012-03-000667
Filing Date
2003-09-29
Accepted
2003-09-29 17:15:09
Documents
13
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT 6/30/03 t300568.txt 10-K 259522
3 exh3-6.txt EX-3.6 24212
4 exh3-7.txt EX-3.7 21933
5 exh10-2.txt EX-10.2 19112
6 EMPLOYMENT AGREEMENT exh10-3.txt EX-10.3 25712
7 exh10-4.txt EX-10.4 4949
8 LIST OF SUBSIDIARIES exh21-1.txt EX-21.1 1418
9 AUDITORS CONSENT exh23-1.txt EX-23 1047
10 CERTIFICATION OF CEO UNDER SECTION 302 exh31-1.txt EX-31 2901
11 CERTIFICATION OF CFO UNDER SECTION 302 exh31-2.txt EX-31 2820
12 CERTIFICATION OF CEO & CFO UNDER SECTIION 906 exh32-1.txt EX-32 1360
13 INCENTIVE STOCK OPTION AGREEMENT exh99-1.txt EX-99.1 14441
14 NON-QUALIFIED STOCK OPTION AGREEMENT exh99-2.txt EX-99.2 14370
  Complete submission text file 0000909012-03-000667.txt   396870
Mailing Address
Business Address 75 ADAMS AVENUE HAUPPAGUE NY 11788 6319520214
INTERPHARM HOLDINGS INC (Filer) CIK: 0000893970 (see all company filings)

EIN.: 133673965 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-15981 | Film No.: 03915668
SIC: 5045 Wholesale-Computers & Peripheral Equipment & Software